|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02637 HAIXI PHARMA
Nominal 
113.300 +0.400 (+0.354%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 |
| Property, plant, equip. & others | 275,057 | 195.805% | 92,986 | 9,597 |
| Land & other Lease Assets | 34,491 | -5.613% | 36,542 | 7,030 |
| Intangible Assets | 0 | -- | 0 | 0 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 |
| Other Non-current Assets | 100,013 | 1.864% | 98,183 | 54,160 |
| 409,561 | 79.860% | 227,711 | 70,787 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Inventories | 35,333 | 42.466% | 24,801 | 28,373 | |
| Trade Receivables | 19,808 | 1.118% | 19,589 | 6,034 | |
| Cash & Bank Balances | 38,282 | -84.948% | 254,324 | 171,477 | |
| Other Current Assets | 252,835 | 619.938% | 35,119 | 144,289 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | |
| 346,258 | 3.722% | 333,833 | 350,173 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||
| Trade Payables | 15,783 | 462.874% | 2,804 | 3,109 | ||
| S-T Debt & Leases | 24,634 | 123.154% | 11,039 | 49,316 | ||
| Other Current Liabilities | 141,656 | 37.262% | 103,201 | 37,660 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | ||
| 182,073 | 55.559% | 117,044 | 90,085 | |||
| Net Current Assets | 164,185 | -24.265% | 216,789 | 260,088 | ||
| Total Assets Less Current Liabilities | 573,746 | 29.077% | 444,500 | 330,875 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||||
| L-T Debt & Leases | 32,248 | -17.421% | 39,051 | 42,861 | |||
| Other Non-current Liabilities | 171 | -15.347% | 202 | 233 | |||
| 32,419 | -17.410% | 39,253 | 43,094 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||||
| Share Capital | 67,207 | 0.000% | 67,207 | 67,207 | ||||
| Reserves | 474,120 | 40.256% | 338,040 | 220,574 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| Shareholders' Funds | 541,327 | 33.580% | 405,247 | 287,781 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| 541,327 | 33.580% | 405,247 | 287,781 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Commitments | 27,015 | -80.815% | 140,812 | 2,834 |
| Contingent Liabilities | 0 | -- | 0 | 0 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 136,079 |
| %Change | 15.857% |
| EPS / (LPS) | RMB 2.020 |
| NBV Per Share (¥) | RMB -- |